Paytm stock price target raised to INR1,250 by UBS on regulatory clarity

UBS has raised its price target for One 97 Communications Ltd (Paytm) to INR1,250 from INR1,100, while maintaining a Neutral rating, primarily due to the resolution of regulatory issues, specifically the receipt of a payment aggregator license, which is seen as a re-rating event. The firm projects Paytm's revenue to grow at a 22% CAGR and EBITDA margins to improve to 15% by FY28E. However, UBS's Neutral stance reflects ongoing concerns regarding a lack of progress in customer additions, potential business loan delinquencies, and the stock's current high valuation of 7.1x EV/1Y forward sales and 62x P/FY27E EPS, which, despite being in line with Indian internet peers, limits further upside potential.

Analysis

UBS has raised its price target on One 97 Communications Ltd (Paytm) to INR1,250 from INR1,100, primarily driven by the resolution of key regulatory uncertainties. The receipt of a payment aggregator license is viewed as a significant "re-rating event," prompting UBS to lower its cost of equity assumption and raise EPS estimates. The bank projects a robust 22% revenue CAGR for Paytm and forecasts a substantial improvement in EBITDA margin from 4% in FY26E to 15% in FY28E, citing progress on cost efficiencies and the scale-up of merchant lending. Despite these positive developments and a growth outlook that outpaces the broader industry, UBS has maintained its Neutral rating. This cautious stance is informed by specific headwinds, including a lack of progress in customer additions and the risk of cyclical pressure on revenues from potential delinquencies in the business loan portfolio. Furthermore, the stock's current valuation at an all-time high of 7.1x EV/1Y forward sales and 62x P/FY27E EPS is considered a limiting factor, suggesting that while the valuation is in line with Indian internet peers, it leaves limited room for further upside.

Key Decisions for Investors

• Given the stock's valuation at 7.1x forward sales and UBS's Neutral rating, investors should exercise caution as the current price may already reflect the positive regulatory news, potentially limiting near-term upside.
• Monitor key operational metrics closely, specifically customer acquisition growth and business loan delinquency rates, as any improvement could serve as a catalyst for a re-rating, while deterioration would validate the current cautious outlook.
• For long-term holders, the projected 22% revenue CAGR and significant margin expansion present a compelling growth story, but the fair valuation suggests a hold strategy may be more prudent than accumulating a larger position at current levels.